Visual complaints from rheumatoid arthritis patient

Abstract

Hydroxychloroquine (HCQ) is widely used in treating rheumatological diseases all along, and recently popular under the controversy in COVID-19 treatment. There is no doubt HCQ is more widely used clinically nowadays worldwide. Rheumatoid arthritis itself is associated with some ocular pathologies, whereas its treatment with HCQ and oral steroid also posed some harms to the eyes. The pattern of HCQ retinopathy from toxicity was found to be racially different particularly on Asian patients. Wwe present a case of HCQ retinopathy, who was on prolonged (16 years) treatment, with a borderline dosage of ~6mg/kg/day.